282P Impact of artificial intelligence (AI) on follow-up of incidental lung nodules: A US multi-center ambispective study

Missed or delayed follow-up of incidental lung nodules can adversely impact outcomes in lung cancer. This study aims to assess the impact of AI-supported clinics on the number of incidental lung lesions being followed up within pulmonary and thoracic oncology care pathways. We investigate the real-world clinical use of an FDA-approved AI tool combining automatic patient identification and tracking with radiomics-based risk stratification to support clinical decisions.